Onderneming Entasis Therapeutics Holdings Inc.
Aandelen
ETTX
US2936141033
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 51
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01-05-15 |
Ruben Tommasi
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-05-15 |
David Altarac
CTO | Chief Tech/Sci/R&D Officer | 63 | 04-11-19 |
Kyle Dow
IRC | Investor Relations Contact | - | - |
Matthew Ronsheim
PRN | Corporate Officer/Principal | 52 | 01-09-20 |
Anna Diaz Triola
PRN | Corporate Officer/Principal | - | 19-07-21 |
John Mueller
PRN | Corporate Officer/Principal | 64 | 01-05-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hastings
BRD | Director/Board Member | 62 | 01-04-18 |
Director/Board Member | 58 | 01-08-17 | |
Heather Behanna
BRD | Director/Board Member | 49 | 01-08-17 |
David Meek
CHM | Chairman | 59 | 24-06-19 |
Marianne Zhen
BRD | Director/Board Member | 55 | 11-07-22 |
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01-05-15 |
Pavel Raifeld
BRD | Director/Board Member | 40 | 11-07-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 47 851 779 | 44 441 302 ( 92,87 %) | 0 | 92,87 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,65% | 104 mld. | |
+6,75% | 97,47 mld. | |
+5,71% | 22,25 mld. | |
-12,60% | 21,68 mld. | |
-9,70% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-10,17% | 16,36 mld. | |
+6,12% | 14,39 mld. | |
+35,47% | 12,37 mld. |